A global research collaboration, including scientists from the University of Liverpool, has provided new insights into superheavy elements by exami ...

The exposure-response model is a nonlinear, mixed-effects Emax model that included repeated measurements of RPF for each subject in the study (>200 data points), resulting in a modeled E max (maximum ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

With shorter treatment durations, a universal regimen, and innovations that help simplify treatment – including once-daily ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

Alteogen Inc. (KOSDAQ:196170) announced today that the company has entered into an exclusive license agreement with Daiichi Sankyo (TSE: 4568). Under the terms of the agreement, Daiichi Sankyo will ...